Polyprox Therapeutics

Developer of drugs for treatment of cancer

placeCambridge, England, United Kingdom calendar_todayFounded 2018 groups9 employees language polyprox.com

Registered entities

Investor mix

14 investors on record; lead investors include Cambridge Innovation Capital, RT Capital.

Investor typeCountShare
Venture capital321%
Private equity17%
Other / undisclosed1071%
Coming soon